| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000047867 |
| Receipt No. | R000054574 |
| Scientific Title | Change confirmation test of hair strength using a royal jelly |
| Date of disclosure of the study information | 2022/06/03 |
| Last modified on | 2022/11/25 (Ver. 2) |
| Basic information | ||
| Public title | Change confirmation test of hair strength using a royal jelly | |
| Acronym | Change confirmation test of hair strength using a royal jelly | |
| Scientific Title | Change confirmation test of hair strength using a royal jelly | |
| Scientific Title:Acronym | Change confirmation test of hair strength using a royal jelly | |
| Region |
|
|
| Condition | ||
| Condition | Adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effect of Royal jelly for healthy adults for 4 weeks on hair strength. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We confirm effectiveness by measuring hair strength.
(Measuring before and 4week after intake of test food.). |
| Key secondary outcomes | Hair diameter
Amount of active sulfur in hair Hair and pore score Questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | test foods containing royal jelly
Intake:300 mg Ingesion:28day |
|
| Interventions/Control_2 | placebo
Ingesion:28day |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Target subjects must satisfy the following selection criteria.
1. Healthy Japanese women aged more than 20 years and lsee than 59 years at the time of giving informed consent. 2. Subjects who understands that clinical visits are mandatory during clinical study period. 3. Subjects who has freely given consent and has understood the purpose of the study. |
|||
| Key exclusion criteria | The subjects in conflict with any of the following condition are excluded.
1. Subjects who have current or history of food allergies or asthma. 2. Subjects who had participated in other clinical trials such as application tests of other hair growth agents / cosmetics and drinking tests of beauty foods within the last 4 weeks prior to the current study. 3. Subjects who cannot stop taking RJ-containing foods during the test period 4. Subjects who have trauma or inflammation on the scalp. 5. Subjects with atopic dermatitis and chronic skin diseases. 6. Subjects who are using hair growth agents and hair growth agents. 7. Subjects in pregnancy or in nursing. 8. Subjects who have received "hormone replacement therapy" or taken oral contraceptives within 1 year 9. Subjects with an average hair diameter of 0.06 mm or less 10. Subjects who plan to perform care other than hair care in daily life and hair dyeing / bleaching during the test period. 11. Subjects who are judged as unsuitable for the current study by the investigator for other reasons. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yamada Bee Company, Inc. | ||||||
| Division name | Functional lngredient research section, Institute for Bee Products & Health Science, R&D department | ||||||
| Zip code | 708-0393 | ||||||
| Address | 194 Ichiba, Kagamino-cho, Tomata-gun, Okayama 708-0393 Japan | ||||||
| TEL | 0868-54-3825 | ||||||
| ay1255@yamada-bee.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yamada Bee Company, Inc. | ||||||
| Division name | Functional lngredient research section, Institute for Bee Products & Health Science, R&D department | ||||||
| Zip code | 708-0393 | ||||||
| Address | 194 Ichiba, Kagamino-cho, Tomata-gun, Okayama 708-0393 Japan | ||||||
| TEL | 0868-54-3825 | ||||||
| Homepage URL | |||||||
| hi1727@yamada-bee.com | |||||||
| Sponsor | |
| Institute | Yamada Bee Company, Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yamada Bee Company, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Bioscience, Tokushima University |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yamada Bee Company Ethics Committee |
| Address | 194 Ichiba, Kagamino-cho, Tomata-gun, Okayama 708-0393 Japan |
| Tel | 0868-54-1199 |
| hi1727@yamada-bee.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054574 |